Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 941-492-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 09 July 2014 and 03 September 2014
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- The reliability is rated 1 because the study followed the standard guideline of reference (OECD 471), which describes a procedure designed to evaluate this endpoint, the results were reviewed for reliability and assessed as valid, and the study was conducted under GLP condition.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 from liver of rodent treated with Aroclor
- Test concentrations with justification for top dose:
- C1 : 0.015 mg/plate
C2 : 0.045 mg/plate
C3 : 0.15 mg/plate
C4 : 0.45 mg/plate
C5 : 1.5 mg/plate
Concentration were prepared by serial dilutions in the selected solvent from a stock solution of 30 mg/ml. - Vehicle / solvent:
- - Solvent used: ethanol (96%)
- Justification for choice of solvent: The ethanol (96%) was chosen as the test item was soluble in it at a concentration of 50.0 mg/mL - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- benzo(a)pyrene
- mitomycin C
- other: 2-Anthramine
- Remarks:
- The positive controls used are different for tests with and without metabolic activation or for different tester strains (see the "section Any other information on materials and methods incl.tables" for more details)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: under the direct incorporation of agar medium plate and the pre-incubation procedures
DURATION
- Preincubation period: 30 min at 37°C when the pre-incubation procedure is used.
- Exposure duration: 48-72 hr at 37°C
- Expression time (cells in growth medium): counting completed at the end of the exposure period in each plate
NUMBER OF REPLICATIONS: Triplicate, in parallel with negative and positive controls and the solvent of test material.
DETERMINATION OF CYTOTOXICITY
- Method: decrease in the number of revertant colonies or a clearing or diminution of the background lawn. - Evaluation criteria:
- A positive result involved taking into account a dose-response effect in the range tested and/or a reproducible increase at one or more concentrations in the number of revertant colonies per plate in at least one strain with or without metabolic activation system.
The result is considered positive whenever the number of revertants of the test item treated plates is higher than those observed in the solvent treated plates, according to the following criteria:
- TA98 strain : 2 fold higher
- TA100 strain: 2 fold higher
- TA1535 strain : 3 fold higher
- TA1537 strain : 3 fold higher
- WP2 (pkM101) : 2 fold higher
The biological relevance of the results was also considered. - Statistics:
- no statistic was used
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at the highest dose
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- COMPARISON WITH HISTORICAL CONTROL DATA:
The mean solvent control and reference item control counts complied with the laboratory historical data for each strain - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative
Under these conditions, the test item, Sepisol Fast Yellow MG-F does not induce any mutagenic change in Salmonella typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102, without or with metabolic activation, according to the OECD Guidelines n°471 and the method B13/B14 of the directive 2000/32/CE. - Executive summary:
Five doses (15 μg/plate to 1 500 μg/plate) of the solutions obtained from the test item, Sepisol Fast Yellow MG-F, have been tested for their capacity to induce reverse mutation in five Salmonella typhimurium strains. This study was performed in the absence and presence of metabolic activation. Two independent assays were carried out.
For assay n°1, five doses (15 μg/plate to 1 500 μg/plate) of the solutions obtained from the test item, Sepisol Fast Yellow MG-F were put in contact with the strains in the absence and presence of a metabolic activation system (S9-mix 10 % (v/v)).
For assay n° 2, five doses (15 μg/plate to 1 500 μg/plate) of the solution obtained from the test item, Sepisol Fast Yellow MG-F were put in contact with the strains in the absence of metabolic activation and with pre-incubation in the presence of metabolic activation system (S9-mix 10 % (v/v)).
For the two assays, negative and positive controls were carried out in parallel. Positive controls induced a significant increase in the number of revertant colonies compared to negative controls. There is no significant difference between the number of spontaneous reversions, the number of reversions obtained in the positive controls (without and with metabolic activation), and the mean of corresponding experimental “historical” values obtained in the laboratory (Table 11).
These results validate the two tests.
There is no evidence of any increase in the number of revertant colonies in the presence of the various concentration of the test item (1 500, 450, 150, 45 et 15 μg/plate), without and with metabolic activation, in Salmonella typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102.
Therefore, under these conditions, the test item, Sepisol Fast Yellow MG-F - Batch N°407940 (LEMI code : GAG020714) provided by BIMA 83 do not induce any mutagenic change in Salmonella typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102, without or with metabolic activation, according to the OECD Guidelines n°471 and the method B13/B14 of the directive 2000/32/CE.
- Endpoint:
- in vitro cytogenicity / micronucleus study
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2017-03-23 to 2017-04-21
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 487 (In vitro Mammalian Cell Micronucleus Test)
- Version / remarks:
- July 29th, 2016
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell micronucleus test
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: 407940
- Expiration date of the lot/batch: 2024
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: at room temperature
- Stability under test conditions: stable
- Solubility and stability of the test substance in the solvent/vehicle: soluble in ethanol, stability in the solvent of 96 hrs.
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing:
- Preliminary purification step (if any):
- Final dilution of a dissolved solid, stock liquid or gel:
- Final preparation of a solid: - Target gene:
- L5178Y TK+/-
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Additional strain / cell type characteristics:
- other: TK+/- clone (3.7.2C)
- Cytokinesis block (if used):
- not used
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9
- Test concentrations with justification for top dose:
- Test concentrations: 3.12 µg/ml, 6.25 µg/ml, 12.5 µg/ml, 25 µg/ml, 50 µg/ml, 50 µg/ml, 100 µg/ml, 200 µg/ml, 400 µg/ml.
Concentration defined according to its solubility. The highest concentration corresponded ot the mother solution, being the solubility limit concentration, diluted 100 times - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: ethanol
- Justification for choice of solvent/vehicle: substance soluble in ethanol and stable for 96 hours - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- other: Colchicine
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium; in agar (plate incorporation); preincubation; in suspension; as impregnation on paper disk
- Cell density at seeding (if applicable): 2.10^6 cells in suspension/tube
DURATION
- Exposure duration:
* short treatment : 4 hours +/- 1 hour with and without metabolic activation
* long treatment: 24 hours +/- 1 hour without metabolic activation
- Expression time (cells in growth medium): short treatment: 1.5 to 2 times the duration of the cell cycle (i.e. 20-24 hours)
- Fixation time (start of exposure up to fixation or harvest of cells):
* short treatement : fixation time ~ 24 to 28 hours after start of exposure
* long treatment: fixation time ~ 24 hours after start of exposure
STAIN (for cytogenetic assays): solution of 5% Giemsa in Sorensen buffer
NUMBER OF REPLICATIONS:
* test concentration: 2 replicates
* Solvant control: 2 replicates
* Positive control: 4 replicates
METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED:
* 2 or 3 drops of the fixed cell suspension deposited on a clean glass slide
* All slides are coded before microscopic analysis
* 3 replicates carried out individually for each duplicate culture
* Stained during 15 to 20 minutes and then rinsed 3 times (1st bath with Sorensen buffer for 1 minute, 2 baths with demineralized water during 2 minutes each).
* Slides dried at room temperature
NUMBER OF CELLS EVALUATED: 1 000 cells/slide, 2 slides analysed
CRITERIA FOR MICRONUCLEUS IDENTIFICATION:
* Independent nuclear entities, non-refractive, not linked to the main nucleus,
* Staining intensity micronucleus lower or equal to that of the main nucleus,
* Size of the micronucleus is from 1/3 to 1/16 the size of the main nucleus,
* Clearly surrounded by a nuclear membrane,
* No contact with the main nucleus and located within the cytoplasm,
* Micronucleus number between 1 and 5.
* Cells not counted:
- mononuclear cells containing more than 5 micronuclei (to exclude the phenomena of apoptosis or DNA fragmenation)
- cells with an irregular shape
DETERMINATION OF CYTOTOXICITY
- Method: evaluation of the number after application compared to the inital cell number and by measuring the relative increase in cells or the cell population doubling.
- Any supplementary information relevant to cytotoxicity: measures performed for all cultures. - Evaluation criteria:
- Determination of a positive result:
* at least one concentration shows a statistically significant increase in the nomber of cells with micronuclei as compared with the negative control
* existence of a dose effect
* results are outside of the data distribution range of historical negative control.
(reproducibility and historical negative control) - Statistics:
- Chi-2 test (χ²) performed with α=0.05. P < 0.05
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- concentrations with a cytotoxicity lower than 55%+/-5% were selected for reading and analyzing slides for genotoxicity testing.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- NUMBER OF CELLS WITH MICRONUCLEI
- Number of cells for each treated and control culture: see table X below
HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%)
- Positive historical control data and Negative (solvent/vehicle) historical control data : see attached document
ADDITIONAL INFORMATION ON CYTOTOXICITY:
- Measurement of cytotoxicity used: based on RPD
Referenceopen allclose all
Cytotoxicity Results
Cytotoxicity evaluated using cytostasis parameter.
The concentrations selected for reading and analyzing slides for genotoxicity testing where those presenting a cytotoxicity lower than 55% +/-5% (the selected concentrations are appearing in orange in the table 1 below).
Table 1: cytotoxicity data at the 3 test conditions
|
Number of cells by line |
Doubling population % |
Cytostasis % |
|
4 hours without metabolic activation |
||||
Negative control |
64 |
70 |
172% |
0% |
58 |
72 |
|||
Clastogenic positive control Mitomycin C 0.2 µg/ml |
42 |
40 |
101% |
41% |
37 |
42 |
|||
Aneugenic positive control Colchicine 0.1 µg/ml |
27 |
24 |
31% |
82% |
26 |
22 |
|||
400 µg/ml |
0.1 |
0.1 |
0% |
100% |
0.1 |
0.1 |
|||
200 µg/ml |
0.1 |
0.1 |
0% |
100% |
0.1 |
0.1 |
|||
100 µg/ml |
24 |
28 |
42% |
76% |
27 |
28 |
|||
50 µg/ml |
24 |
26 |
62% |
64% |
27 |
28 |
|||
25 µg/ml |
64 |
72 |
172% |
0% |
62 |
66 |
|||
12.5 µg/ml |
63 |
70 |
172% |
0% |
67 |
64 |
|||
6.25 µg/ml |
67 |
69 |
175% |
-2% |
72 |
61 |
|||
3.12 µg/ml |
65 |
70 |
178% |
-3% |
68 |
71 |
|||
4 hours with metabolic activation |
||||
Negative control |
74 |
79 |
196% |
0% |
73 |
76 |
|||
Clastogenic positive control CP 1.5 µg/ml |
53 |
47 |
131% |
33% |
54 |
44 |
|||
400 µg/ml |
0 |
0 |
0% |
100% |
0 |
0 |
|||
200 µg/ml |
0 |
0 |
0% |
100% |
0 |
0 |
|||
100 µg/ml |
53 |
53 |
131% |
33% |
45 |
47 |
|||
50 µg/ml |
68 |
68 |
187% |
5% |
76 |
81 |
|||
25 µg/ml |
80 |
84 |
197% |
0% |
76 |
74 |
|||
12.5 µg/ml |
77 |
75 |
194% |
1% |
74 |
80 |
|||
6.25 µg/ml |
78 |
81 |
195% |
1% |
71 |
79 |
|||
3.12 µg/ml |
74 |
77 |
194% |
1% |
84 |
72 |
|||
24 hours without metabolic activation |
||||
Negative control |
113 |
97 |
236% |
0% |
111 |
91 |
|||
Clastogenic positive control Mitomycin C 0.02 µg/ml |
86 |
80 |
205% |
13% |
73 |
92 |
|||
Aneugenic positive control Colchicine 0.01 µg/ml |
120 |
123 |
243% |
-3% |
98 |
90 |
|||
50 µg/ml |
1 |
4 |
-300% |
227% |
3 |
2 |
|||
25 µg/ml |
25 |
26 |
-11% |
105% |
13 |
10 |
|||
12.5 µg/ml |
52 |
59 |
145% |
39% |
48 |
59 |
|||
6.25 µg/ml |
85 |
88 |
200% |
15% |
71 |
76 |
|||
3.12 µg/ml |
99 |
86 |
216% |
9% |
88 |
84 |
|||
1.56 µg/ml |
92 |
84 |
210% |
11% |
85 |
82 |
|||
0.78 µg/ml |
132 |
136 |
263% |
-11% |
120 |
107 |
|||
0.39 µg/ml |
109 |
113 |
244% |
-3% |
104 |
109 |
Genotoxicity
Table 2: genotoxicity at the 3 test conditions
|
Mononuclear cells number |
Micronucleated cells number |
Statistical test |
P-value |
Interpretation |
4 hours without metabolic activation |
|||||
Negative control |
996 |
4 |
- |
- |
- |
996 |
4 |
||||
Clastogenic positive control Mitomycin C 0.2 µg/ml |
819 |
181 |
CHI 2 |
3.85E-92 |
Significative |
785 |
215 |
||||
Aneugenic positive control Colchicine 0.1 µg/ml |
919 |
81 |
CHI 2 |
5.59E-39 |
Significative |
896 |
104 |
||||
25 µg/ml |
996 |
4 |
CHI 2 |
1.00E+00 |
Non significant |
996 |
4 |
||||
12.5 µg/ml |
997 |
3 |
CHI 2 |
1.00E+00 |
Non significant |
995 |
5 |
||||
6.25 µg/ml |
996 |
4 |
CHI 2 |
6.37E-01 |
Non significant |
994 |
6 |
||||
3.12 µg/ml |
993 |
7 |
CHI 2 |
6.37E-01 |
Non significant |
997 |
3 |
||||
4 hours with metabolic activation |
|||||
Negative control |
991 |
9 |
- |
- |
- |
994 |
6 |
||||
Clastogenic positive control CP 1.5 µg/ml |
949 |
51 |
CHI 2 |
6.33E-15 |
Significative |
955 |
45 |
||||
100 µg/ml |
990 |
10 |
CHI 2 |
1.00E+00 |
Non significant |
995 |
5 |
||||
50 µg/ml |
995 |
5 |
CHI 2 |
1.00E+00 |
Non significant |
990 |
10 |
||||
25 µg/ml |
991 |
9 |
CHI 2 |
1.00E+00 |
Non significant |
994 |
6 |
||||
12.5 µg/ml |
993 |
7 |
CHI 2 |
1.00E+00 |
Non significant |
992 |
8 |
||||
24 hours without metabolic activation |
|||||
Negative control |
995 |
5 |
- |
- |
- |
998 |
2 |
||||
Clastogenic positive control Mitomycin C 0.02 µg/ml |
933 |
67 |
CHI 2 |
2.19E-24 |
Significative |
947 |
53 |
||||
Aneugenic positive control Colchicine 0.01 µg/ml |
952 |
48 |
CHI 2 |
6.95E-13 |
Significative |
979 |
21 |
||||
12.5 µg/ml |
998 |
2 |
CHI 2 |
5.63E-01 |
Non significant |
997 |
2 |
||||
6.25 µg/ml |
996 |
4 |
CHI 2 |
7.81E-01 |
Non significant |
998 |
2 |
||||
3.12 µg/ml |
995 |
5 |
CHI 2 |
7.96E-01 |
Non significant |
997 |
3 |
||||
1.56 µg/ml |
999 |
1 |
CHI 2 |
5.63E-01 |
Non significant |
996 |
4 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for classification or non-classification
The standard in vitro genotoxicity test battery performed on the substance (OECD TG 471, 487 and 490) gives negative results
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.